Cryptosporidiosis has been reported in both immunocompetent and immunocompromised patients and it has three major clinical presentations, including; asymptomatic carriage, acute diarrhea, and persistent diarrhea (
1).
Cryptosporidium spp. infection may cause severe clinical gastrointestinal disorders, especially in people infected with human immunodeficiency virus (HIV) (
2), people with malignancies, patients with solid-organ transplants, and hemodialysis patients (
3-
6). Its prevalence has been reported to be 5-50% among patients with AIDS (
7), and it is also an important cause of AIDS-associated deaths due to severe diarrhea.
According to Plutzer and Karanis (
8), 20
Cryptosporidium species have been recognized and approximately 61
Cryptosporidium genotypes have been found with uncertain species status, based on SSU-rRNA sequences. Five
Cryptosporidium species/genotypes are responsible for the most common human cryptosporidiosis cases, including;
Cryptosporidiumhominis,
C. parvum, C. meleagridis,
C. felis, and
C. canis (
9). Among these species,
C.hominis and
C. parvum are the most common agents responsible for the majority of human infections, especially in industrialized nations, even though in some areas, the incidence of
C.
meleagridis infection is as high as
C. parvum (
10). A few other
Cryptosporidium species and genotypes can occasionally cause human infections, including;
C. muris,
C. suis,
C. andersoni and
C. cervine and genotypes (
9,
11,
12).
The role of each transmission route in endemic areas remains unclear, and this is because of the ability of
Cryptosporidium species to infect both humans and a wide variety of animals. In addition to the ubiquitous presence of the organism, the expensive nature of epidemiologic investigations, and the inability to differentiate
Cryptosporidium species by conventional microscopic investigations, makes this process more difficult (
13). Recently the use of molecular methods has significantly helped our understanding of the biology and epidemiology of
Cryptosporidium species (
14). This includes increased knowledge of the species structure and genetics in the
Cryptosporidium population, the roles of various transmission routes in cryptosporidiosis epidemiology, and the significance of parasite genetics in pathogenesis and clinical presentations (
15). These recent developments have enabled researchers to provide more accurate risk assessments on environmental and drinking water contamination, and it has also helped health officials to better educate the public about the risk factors involved in the acquisition of cryptosporidiosis in vulnerable populations (
16,
17). There is little information regarding cryptosporidiosis in the region and no current molecular
Cryptosporidium characterization data are available.